ada tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies Compounded GLP-1/GIP (Tirzepatide) - bmiMD
Description
The net effect of KES highly depends on the frequency, amplitude, and overall duration of the applied stimulus
TPO Ab, thyroid peroxidase antibody
Diabetes Care 2021;44(4): 10551058
These findings mirror the recent Compass Pathways Phase 3 readouts, which similarly delivered met endpoints but left some clinicians and researchers (like myself) feeling underwhelmed
Elizabeth Wood hasn't had any negative side effects
You need to hold them for 3-5 minutes
